Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies

Neuroscience

Volumn 158, Issue 4, 2009, Pages 1478-1487

  Vivacqua, G ^a,b   Yin, J J ^a   Casini, A ^b   Li, X ^a   Li, Y H ^a   D'Este, L ^b   Chan, P ^a   Renda, T G ^b   Yu, S ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

immunohistochemistry; nervous system; Parkinson disease; spinal cord; synucleins

Indexed keywords

ALPHA SYNUCLEIN; CALBINDIN; CALRETININ; EPITOPE; MONOCLONAL ANTIBODY; NEUROPEPTIDE Y; SYNAPTOPHYSIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; DYSAUTONOMIA; GRAY MATTER; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; NERVE ENDING; NONHUMAN; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SPINAL CORD; WISTAR RAT;

ALPHA-SYNUCLEIN; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; NEUROPEPTIDE Y; RATS; RATS, WISTAR; SPINAL CORD; SYNAPTOPHYSIN; TYROSINE 3-MONOOXYGENASE;

EID: 60349099757     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.12.001     Document Type: Article

References (51)

1. Ahn T.B., Kim S.V., Kim J.V., Park S.S., Lee D.S., Min H.J., Kim Y.K., Kim S.E., Kim J.M., Kim H.J., Cho J., and Jeon B.S. alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70 1 (2008) 43-49
2. Arima K., Uèda K., Snohara N., Hiral S., Izumlyama Y., Tonozuka-Uehara H., and Kawai M. Immunoelectron microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808 (1998) 93-100
3. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., and Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152 (1998) 879-884
4. Bannister R., and Mathias C.J. Clinical features and evaluation of primary chronic autonomic failure syndromes. In: Mathias C.J., and Bannister R. (Eds). Autonomic failure. 4th ed (1999), Oxford University Press, Oxford, UK 307-316
5. Braak H., Bohl J.R., Muller C.M., Rub U., De Vos R.A., and Del Tredici K. Stanley Fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 21 12 (2005) 2042-2051
6. Braak H., Ghebremedhin E., Rub U., Bratzke H., and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 (2004) 121-134
7. Chaudhuri K.R. Autonomic dysfunction in movement disorders. Curr Opin Neurol 14 (2001) 505-511
8. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., and Wiliamson R.E. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: implications of pathogenesis and therapy. Proc Natl Acad Sci U S A 97 (2000) 571-576
9. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Harper J.D., Wiliamson R.E., and Lansbury Jr. P.T. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann N Y Acad Sci 920 (2000) 42-45
10. Croisier E., MRes D.E., Deprez M., Goldring K., Dexter D.T., Pearce R.K., Graeber M.B., and Roncaroli F. Comparative study of commercially available anti-alpha-synuclein antibodies. Neuropathol Appl Neurobiol 32 3 (2006) 351-356
11. Duggan A.W., Hope P.J., and Lang C.W. Microinjection of neuropeptide Y into the superficial dorsal horn reduces stimulus-evoked release of immunoreactive substance P in anaesthetized cat. Neuroscience 44 3 (1991) 733-740
12. Feany M.B., and Bender W.W. A Drosophila model of Parkinson's disease. Nature 404 (2000) 394-398
13. Ford B. Pain in Parkinson's disease. Clin Neurosci 5 (1998) 63-72
14. Giasson B.I., Duda J.E., Murray I.V., Chen O., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.O., and Lee W.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290 5493 (2000) 985-989
15. Giasson B.I., Murray I.V., Trojanowski J.O., and Lee W.M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 276 4 (2001) 2380-2386
16. Goldstein D.S., Holmes C., Li S.T., Bruce S., Metman L.V., and Cannon III R.O. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133 (2000) 338-347
17. Hardy J., Cai H., Cookson M.R., Gwinn-Hardy K., and Singleton A. Genetics of Parkinson's disease and parkinsonism. Ann Neurol 60 4 (2006) 389-398
18. Iacopino A.M., and Christakos S. Specific reduction of calcium-binding protein (calbindin 28KD) gene expression in aging and neurodegenerative disease. Neurobiol 87 (1990) 4078-4082
19. Klos K.J., Ahlskog J.E., Josephs K.A., Apaydin H., Parisi J.F., Boeve B.F., DeLucia M.W., and Dikson D.W. Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 66 7 (2006) 1100-1102
20. Krüger R., Kuhn W., Muller T., Woitalia D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18 (1998) 106-108
21. Lavedan C. The synuclein family. Genome Res 8 (1998) 871-880
22. Li J.Y., Henning Jensen P., and Dahlstrom A. Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience 113 (2002) 463-478
23. Maguire-Zeiss K.A., Wang C.I., Yehling E., Sullivan M.A., Short D.W., Su X., Gouzer G., Henricksen L.A., Wuertzer C.A., and Federoff H.J. Identification of human alpha-synuclein specific single chain antibodies. Biochem Biophys Res Commun 349 4 (2006) 1198-1205
24. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Krüger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., Hulihan M.M., Aasly J.O., Ashizawa T., Chartier-Harlin M.C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.C., Lynch T., Mellick G.D., Papapetropoulos S., Parsian A., Quattrone A., Riess O., Tan E.K., and Van Broeckhoven C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296 6 (2006) 661-670
25. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
26. Mori F., Tanji K., Yoshimoto M., Takahashi H., and Wakabayashi K. Immuno-histochemical comparison of alpha- and beta-synuclein in adult rat central nervous system. Brain Res 94 (2002) 118-126
27. Mouatt-Prigent A., Agid Y., and Hirsch E.C. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?. Brain Res 668 1-2 (1994) 62-70
28. Moussa C.E., Wersinger C., Tomita Y., and Sidhu A. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Biochemistry 43 (2004) 5539-5550
29. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2 (2003) 107-116
30. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Robenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.J., Lazzarini A.M., Devoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
31. Rexed B. The cytoarchitectonic organization of the spinal cord in the cat. J Comp Neurol 96 (1952) 415-495
32. Rexed B. A cytoarchitectonic atlas of the spinal cord in the cat. J Comp Neurol 100 (1954) 297-379
33. Rexed B. Some aspects of cytoarchitectonic and synaptology of the spinal cord. Prog Brain Res 11 (1964) 58-92
34. Scherder E., Wolters E., Polman C., Sergeant J., and Swaab D. Pain in Parkinson's disease and multiple sclerosis: its relation to the medial and lateral pain system. Neurosci Biobehav Rev 29 (2005) 1047-1056
35. Schott G.D. Pain in Parkinson's disease. Pain 22 (1985) 407-411
36. Shibasaki Y., Baillie D.A., St. Clair D., and Brookes A.J. High-resolution mapping of SNCA encoding α-synuclein, the non Aβ component of Alzheimer disease amyloid precursor to human chromosome 4q21.3-q22 by fluorescence in situ hybridization. Cytogenet Cell Genet 71 (1995) 54-55
37. Singleton A., Gwinn-Hardy K., Sharabi Y., Li S.T., Holmes C., Dendi R., Hardy J., Singleton A., Crawley A., and Goldstein D.S. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127 4 (2004) 768-772
38. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 95 (1998) 6469-6473
39. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowsky J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
40. Tinazzi M., del Vesco C., Fincati E., Ottaviani S., Smania N., Moretto G., Fiaschi A., Martino D., and Defazio G. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 77 (2006) 822-825
41. Tokeda A., Mallory M., Sundsmo M., Honer W., Hansen L., and Misliah E. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 152 (1998) 367-372
42. Uèda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A., Kondo J., Ihara Y., and Saitch T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90 (1993) 11282-11286
43. Urakami K., Takahashi K., Matsushima E., Sano K., Nishikawa S., and Takao T. The threshold of pain and neurotransmitter's change on pain in Parkinson's disease. Jpn J Psychiatry Neurol 44 3 (1990) 389-393
44. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., Lansbury P.T., and NACP. A protein implicated in Alzheimer disease and learning, is natively unfolded. Biochemistry 35 (1996) 13700-13715
45. Wiesenfeld-Hallin Z., and Xu X.J. Neuropeptide in neuropathic pain and inflammatory pain with special emphasis on cholecystokinin and galanin. Eur J Pharmacol 492 (2001) 49-59
46. Xu J., Kao S.Y., Lee F.J.S., Song W., Jin L.W., and Yankner B.A. Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8 (2002) 600-606
47. Yamada M., Iwatsubo T., Mizuno Y., and Mochizuki H. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. J Neurochem 91 (2004) 451-461
48. Yu S., Li X., Liu G., Han J., Zhang C., Li Y., Xu S., Liu C., Gao Y., Yang H., Uèda K., and Chan P. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145 (2007) 539-555
49. Yu S., Uéda K., and Chan P. α-Synuclein and dopamine metabolism. Mol Neurobiol 31 1-3 (2005) 243-254
50. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Liorens V., Gomez Tortosa E., Del Ser T., Munoz D.G., and De Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55 (2004) 164-173
51. Zhou W., Hurlbert M.S., Schaack J., Prasad K.M., and Freed C.R. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res 866 (2000) 33-43